Homology Medicines Reports Second Quarter 2018 Financial Results

BEDFORD, Mass., Aug. 13, 2018 /PRNewswire/ -- Homology Medicines, Inc. (Nasdaq: FIXX), a genetic medicines company, announced today financial results for the quarter ended June 30, 2018, and highlighted recent accomplishments. "During the quarter, we progressed IND-enabling studies of our ...